高管在22nd Century Group变化

Cliff Fleet已作为Director, President and Chief Executive Officer加入公司  (新闻发布的20198月5号).
Henry Sicignano, President, Chief Executive Officer and Director, 已经离开公司  (新闻发布的20198月5号).
Michael Zercher 曾任 Vice President of Business Development, 现升职为 Chief Operating Officer  (新闻发布的20196月17号).

更多的变化在％s

创建提醒
跟踪 22nd Century Group 的高管变动

Latest M&A news in 生物技术.

Astellas Pharma has announced the acquisition of Audentes Therapeutics (posted on 12月 5, 2019).
Mesa Laboratories has announced the acquisition of Gyros (posted on 11月 1, 2019).
WebMD Health has announced the acquisition of Aptus Health (posted on 9月 30, 2019).

是其中之一......

• Russell 3000.

22nd Century Group 搜索最多的简介

• Cliff Fleet, Director, President and Chief Executive Officer
• Richard Sanders, Director
• James Cornell, Chairman of the Board

单击任一高管查看其简介 >

生物技术 行业的其他推荐联系人

• UroGen 企业 Fred Cohen - Director
• Lonza 企业 Sylke Hassel - Senior Vice President and Global Head of Mammalian Busines
• Parallel 企业 Fareed Khan - Chief Financial Officer

了解更多有关生物技术行业的信息 >

有关 22nd Century Group 的最新新闻

22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc. :: 22nd Century Group, Inc. (XXII)
22nd Century Group Comments on Delay of Reduced Nicotine Rule for Cigarettes :: 22nd Century Group, Inc. (XXII)
22nd Century Group, Inc. | Company History
22nd Century Group, Inc. | Company History
22nd Century Group, Inc. | Company History

22nd Century Group 在 维基百科、谷歌新闻 和 雅虎财经

22nd Century Group 在 LinkedIn、叽叽喳喳 和 YouTube

22nd Century Group 拥有 1,320 家竞争者，其中包括 Alltech (美国(美洲))、Aldeyra Therapeutics (美国(美洲)) 和 Charles River Laboratories International (美国(美洲))。

通过电子邮件联系联系该企业高管，包括 James Cornell

致电22nd Century Group，电话：+1 716...

查看组织结构图

Register to receive your alert

报告错误